You are here: Home » Companies » Results
Business Standard

Ajanta Pharma Q2 net profit dips 7% to Rs 116 crore; stock ends flat

Income from operations rose to Rs 643 crore during the period under review, as compared with Rs 544 crore in the year-ago period

Press Trust of India  |  New Delhi 

Pharma
Shares of the company on Tuesday ended 0.20 per cent down at Rs 1,002.40 apiece on the BSE

Drug firm on Tuesday reported 7 per cent decline in net profit at Rs 116 crore for the second quarter ended September 30.

The company had posted a net profit of Rs 125 crore in the same period of previous fiscal.

Income from operations, however, rose to Rs 643 crore during the period under review, as compared with Rs 544 crore in the year-ago period, said in a regulatory filing.

Shares of the company on Tuesday ended 0.20 per cent down at Rs 1,002.40 apiece on the BSE.

First Published: Tue, November 05 2019. 20:35 IST
RECOMMENDED FOR YOU